home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 29, 2020
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 521 active entries


SBO Cos. Canada
Toll free: +011-604-941-9022 (helpline)

Phone: +011-604-945-8408 (landline)
Fax: +011-604-941-9022 (FAX)
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it



  We offer the ff. bundle of services for SBO: to Clients

  • Agricultural services (consulting and mentoring future students advancing in their fields)
  • Community services ("go fund me" raising and bottle drives through volunteering)
  • Printing & publishing services (Indie publishing with self-copyright)
  • Research services (paid search and accessing library databases)
  • Fielding Events services (announcements, presentations, meetings, marketing/sales)


We are listed under printing/publishing manufacturing, liaising between academe and industry and disseminating information between the scientific community and the public and bringing information to the public domain including our areas in biotech as part of our professional, scientific and technical activities as biotechnology industry sponsored as an NGO / NPO concern with our proud partners and officially recognized by: Hum-molgen.de (in the FRG) and our home-bases in academia: Kzoo.edu; UNSW.edu.au.  

Providing knowledge through the info commercialization industry (e. g. the Philippine Islands) via the Internet is SkyeBlue's prime objective. SKYEBLUE  is a skeleton membered roster, ongoing, which creates, uses, transforms, consumes and manages information using IT to provide web content for the web. As member, you will help manage computers with PC Wifi, enterprise management software, and contractual obligations to remunerate benefits from private funding and evaluate C.V.s/Resumes for further referral, engage print, copy, photo services, shipping and our makeshift mail room.  SkyeBlue builds on a subscription base for those wishing to hear of the latest and best that advances in biotech in agro, biomass, food and medical areas in the form of news releases and v. bloggings. We have a very visible "label" amongst our websites. We accept payment via banquer's cheque.

We are actively seeking fundraising sources and collaborate sharing interests in common research areas.  We occasionally have enquiries from those starting their careers who are interested in employment (e. g. India).  We cover and focus on: biochemistry, animal nutrition, biotechnology and livestock production with crops and animal feeding, the issue of alternative feeding strategies to support and increase livestock and food production for the growing world population.

We are now situating ourselves in the Central Asian republics and further around as understood with Russian, the Far East, South Asian subcontinent and the Islamic Western Asia (e. g. Turkey). These are research projects with our portfolio that could cover basic, high-risk research, as well as research for greater environmental sustainability, with biotechnology and agriculture, largely in mind. About world Life Bio-Science Hubs and their "techie clusters" will continue to be featured with our web franchisees or outlets - there has been some discourse "on the ground" of seeming developments and sectorization via civil engineering and by activity that portends this as a possibility for the GVRD in near future. (Shocking sudden changes with developments as reported in the press will not surprise "SkyeBlue".)


Principal, writer and trade biotechnologist, (official printing about SBO Cos. started around 2007- to the present time). 

DANNY AGUSTIN is a biotechnologist, writer; b. Dumaguete City, Negros Oriental, Philippines, Apr. 19, 1959; BA in Chemistry, Kalamazoo Coll., 1980; MAppSc, U. NSW Australia, 1988; Attended PhD programme, awarded Friend:Friend to the U New Eng, Australia, 1992-1995, PhD-level Monograph, 2013, by internal/external study; awarded HonDSc, HonDL & HonM.Sc., but declined, the International Biographical Centre and Publishers Concern of the UK in 2015. Awarded the Marquis Lifetime Achievement Award 2018 for his hard work and dedication to his field of interest in the Sciences but also declined but entered into the archives from 2014-. Affiliated as a  Problem solver Ideaconnection.com, Victoria, BC, Canada 2012-; and an Independent Scholar of the Canadian Academy of Independent Scholars, CAIS, Continuing Studies, SFU, Vancouver, BC, Canada 2018-2019 (to consider membership subject to deposition of articles of scholarship from recent career development with grant funding); internet webbased rschr TheRschCoop, Kyoto & NZ, 2013- (by donation only); writer, rschr Skye Blue Orgn, Port Coquitlam, BC, Canada, 2007-. Home and Office: 1440 Barberry Dr Port Coquitlam BC Canada V3B1G3; Office Phone: (604)-945-8408. Fax: (604)-941-9022. E-mail: dannyflorda@gmail.com.

Moratorium: We share the viewpoint of uncertainty even at this time of DNA technology of the recombinant kind that is labelled GMO-type technology. We support instead organic, non-chemical input farming practices for their environmental protection and also for their sustainability and support of the economies world-wide nearing breaking point with overpopulation, pollution (e. g. plastics pollution) and global warming, both the moratorium on GMO relatable technology vs. effectivity of non-GMO product labeling where they are effectively free of transgenic DNA as with GMO cows and their touted medicinal milk product homogenized through ultrasonication in order to breakout the fat micellar fraction and filter both somatic and WBC cellular components as they already have ar rived in dairy treated with DNAase activity, and ultrafiltered and so with the homogenized (just the) egg yolk fraction from eggs of GMO chicken layers with a limit to low-cholesterol as a market feature. - D. A. Flores   

Disclaimer: Website content and opinions expressed herein are not necessarily held by SkyeBlue and its supposed member roster. All rights reserved. D. A. Flores. 2003-2023 (c). 

Selected Categories:
Product Company   Service Company
- General
- Services
- Communications

Last update of this entry: March 26, 2020

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2020 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.